WO2008017928A3 - Method for the prediction of vascular events and the diagnosis of acute coronary syndrome - Google Patents

Method for the prediction of vascular events and the diagnosis of acute coronary syndrome Download PDF

Info

Publication number
WO2008017928A3
WO2008017928A3 PCT/IB2007/002266 IB2007002266W WO2008017928A3 WO 2008017928 A3 WO2008017928 A3 WO 2008017928A3 IB 2007002266 W IB2007002266 W IB 2007002266W WO 2008017928 A3 WO2008017928 A3 WO 2008017928A3
Authority
WO
WIPO (PCT)
Prior art keywords
diagnosis
patient
vascular
prediction
acute coronary
Prior art date
Application number
PCT/IB2007/002266
Other languages
French (fr)
Other versions
WO2008017928A2 (en
Inventor
Sylvie Villard-Saussine
Moal Estelle Le
Isabelle Giuliani
Original Assignee
Bio Rad Pasteur
Centre Nat Rech Scient
Larue Catherine
Sylvie Villard-Saussine
Moal Estelle Le
Isabelle Giuliani
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Rad Pasteur, Centre Nat Rech Scient, Larue Catherine, Sylvie Villard-Saussine, Moal Estelle Le, Isabelle Giuliani filed Critical Bio Rad Pasteur
Priority to EP07804722A priority Critical patent/EP2047276A2/en
Priority to CA002660034A priority patent/CA2660034A1/en
Priority to JP2009523365A priority patent/JP2010500545A/en
Priority to US12/309,870 priority patent/US20090197344A1/en
Publication of WO2008017928A2 publication Critical patent/WO2008017928A2/en
Publication of WO2008017928A3 publication Critical patent/WO2008017928A3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316—Modalities, i.e. specific diagnostic methods
    • A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
    • A61B5/346—Analysis of electrocardiograms
    • A61B5/349—Detecting specific parameters of the electrocardiograph cycle
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Optics & Photonics (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)

Abstract

The present invention relates to a method for the prognosis of a vascular event or the diagnosis of ACS in a patient suspected of being at risk for a vascular event or condition, said patient presenting: - no elevation of the ST segment as seen on an electrocardiogram, and/or - a normal level of at least one necrosis marker, wherein the presence and/or levels of at least two different biochemical markers are measured in a biological sample of said patient, whereby the probability that the patient will experience a vascular event or the vascular-related condition is deduced from the measured presence and/or levels of the biochemical markers such as MPO, sCD40L, IL-6, PaPP-A, CRP, D-dimer, troponin, and proBNP.
PCT/IB2007/002266 2006-08-07 2007-08-07 Method for the prediction of vascular events and the diagnosis of acute coronary syndrome WO2008017928A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP07804722A EP2047276A2 (en) 2006-08-07 2007-08-07 Method for the prediction of vascular events and the diagnosis of acute coronary syndrome
CA002660034A CA2660034A1 (en) 2006-08-07 2007-08-07 Method for the prediction of vascular events and the diagnosis of acute coronary syndrome
JP2009523365A JP2010500545A (en) 2006-08-07 2007-08-07 Methods for predicting vascular events and diagnosing acute coronary syndrome
US12/309,870 US20090197344A1 (en) 2006-08-07 2007-08-07 Method for the prediction of vascular events and the diagnosis of acute coronary syndrome

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US83590306P 2006-08-07 2006-08-07
US60/835,903 2006-08-07
EP06291277.9 2006-08-07
EP06291277A EP1887361A1 (en) 2006-08-07 2006-08-07 Method for the prediction of vascular events

Publications (2)

Publication Number Publication Date
WO2008017928A2 WO2008017928A2 (en) 2008-02-14
WO2008017928A3 true WO2008017928A3 (en) 2008-04-24

Family

ID=37076014

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2007/002266 WO2008017928A2 (en) 2006-08-07 2007-08-07 Method for the prediction of vascular events and the diagnosis of acute coronary syndrome

Country Status (6)

Country Link
US (1) US20090197344A1 (en)
EP (2) EP1887361A1 (en)
JP (1) JP2010500545A (en)
CN (1) CN101568837A (en)
CA (1) CA2660034A1 (en)
WO (1) WO2008017928A2 (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0717637D0 (en) 2007-09-10 2007-10-17 Univ Leiden Future cardiac event biomarkers
WO2009100907A1 (en) * 2008-02-14 2009-08-20 Dianeering Diagnostics Engineering And Research Gmbh Means and methods for assessing the risk of patients presenting to emergency departments based on very low concentrations of troponin i or t or using a combination of markers
CN102016552A (en) * 2008-03-05 2011-04-13 神谷来克斯公司 Methods and compositions for highly sensitive detection of molecules
US7927880B2 (en) 2008-05-21 2011-04-19 Mohan Rajapurkar Methods and kit for early detection of acute coronary syndrome and prediction of adverse cardiac events
ES2420841T3 (en) * 2008-03-05 2013-08-27 Mohan Rajapurkar Procedures for the early detection of acute coronary syndrome and prediction of adverse cardiac events
EP2324358A1 (en) * 2008-07-23 2011-05-25 F. Hoffmann-La Roche AG Monitoring anti-angiogenesis therapy
EP2321651B1 (en) 2008-07-23 2017-08-23 F. Hoffmann-La Roche AG Identification of subjects being susceptible to anti-angiogenesis therapy
EP2331964A1 (en) * 2008-08-13 2011-06-15 Roche Diagnostics GmbH D-dimer, troponin, nt-probnp for pulmonary embolism
JP5678045B2 (en) 2009-06-08 2015-02-25 シンギュレックス・インコーポレイテッド High sensitivity biomarker panel
WO2011060361A1 (en) * 2009-11-13 2011-05-19 Bg Medicine, Inc. Risk factors and prediction of myocardial infarction
CN102062735B (en) * 2009-11-18 2013-09-18 江苏迈迪基因生物科技有限公司 Biomarker diagnostic kit for acute coronary syndrome
JP2013525820A (en) 2010-05-06 2013-06-20 シングレクス、インコーポレイテッド Methods for diagnosing, staging, predicting and identifying treatment responders for the risk of developing rheumatoid arthritis
EP2739974A4 (en) * 2011-08-05 2015-04-08 Alere San Diego Inc Methods and compositions for monitoring heart failure
CN114518458A (en) * 2011-09-30 2022-05-20 私募蛋白质体运营有限公司 Cardiovascular risk event prediction and uses thereof
WO2013075055A2 (en) * 2011-11-16 2013-05-23 Aspenbio Pharma, Inc. Compositions and methods for assessing appendicitis
CN103163295B (en) * 2011-12-08 2015-11-18 吴宗贵 A kind of liquid phase chip reagent box for acute coronary syndrome is with its preparation method
WO2013085367A1 (en) * 2011-12-09 2013-06-13 Kyungpook National University Industry-Academic Cooperation Foundation Cardiac troponin i-targeting peptide and use thereof
CN108226482A (en) 2012-03-26 2018-06-29 埃克塞尔柯尔有限责任公司 For testing and analyzing the device and method of object
US20140273273A1 (en) 2012-11-01 2014-09-18 Christie Mitchell Ballantyne Biomarkers to improve prediction of heart failure risk
RU2513845C1 (en) * 2013-01-28 2014-04-20 федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Хакасский государственный университет им. Н.Ф. Катанова" (ФГБОУ ВПО "ХГУ им. Н.Ф. Катанова") Early diagnostic technique for pulmonary artery thromboembolia
EP3069146A4 (en) * 2013-11-15 2017-04-05 Otago Innovation Limited Biomarker for cardiac disorders
RU2549988C1 (en) * 2013-12-02 2015-05-10 федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Хакасский государственный университет им. Н.Ф. Катанова" (ФГБОУ ВПО ХГУ им. Н.Ф. Катанова) Diagnostic technique for pulmonary thromboembolism based on measuring blood serum interleukin-8
JP2017530356A (en) 2014-09-26 2017-10-12 ソマロジック, インコーポレイテッドSomaLogic, Inc. Prediction and use of cardiovascular risk events
CA3012985A1 (en) 2015-01-27 2016-08-04 Kardiatonos, Inc. Biomarkers of vascular disease
CN106199019B (en) * 2016-07-24 2017-12-26 烟台硕博源生物技术有限公司 A kind of genetic chip and its kit for being used to detect coronary heart disease
ES2689961A1 (en) * 2017-04-19 2018-11-16 Joaquin Sabaris Vilas PORTABLE DEVICE FOR PATIENT CLINICAL PRACTICE (Machine-translation by Google Translate, not legally binding)
CN109907751B (en) * 2019-02-27 2021-02-02 严洋 Laboratory chest pain data inspection auxiliary identification method based on artificial intelligence supervised learning
CN112509700A (en) * 2021-02-05 2021-03-16 中国医学科学院阜外医院 Stable coronary heart disease risk prediction method and device
CN117074685A (en) * 2023-04-10 2023-11-17 中国医学科学院阜外医院 Application of cytokine as biomarker in preparation of isolated coronary artery inflammation diagnosis product

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1363128A2 (en) * 2002-05-14 2003-11-19 F. Hoffmann-La Roche Ag Diagnosis of myocardial infarction and acute coronary syndrom by combination of markers
WO2005045440A1 (en) * 2003-11-07 2005-05-19 Roche Diagnostics Gmbh Proximal markers of arterial thrombosis and inflammation for risk stratification of coronary heart disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7074194B2 (en) * 2003-05-19 2006-07-11 Ischemia Technologies, Inc. Apparatus and method for risk stratification of patients with chest pain of suspected cardiac origin
FR2876453B1 (en) * 2004-10-11 2007-01-12 Biomerieux Sa METHOD FOR IN VITRO EXCLUSION DIAGNOSIS OF ACUTE CORONARY SYNDROMES

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1363128A2 (en) * 2002-05-14 2003-11-19 F. Hoffmann-La Roche Ag Diagnosis of myocardial infarction and acute coronary syndrom by combination of markers
WO2005045440A1 (en) * 2003-11-07 2005-05-19 Roche Diagnostics Gmbh Proximal markers of arterial thrombosis and inflammation for risk stratification of coronary heart disease

Also Published As

Publication number Publication date
EP2047276A2 (en) 2009-04-15
CN101568837A (en) 2009-10-28
US20090197344A1 (en) 2009-08-06
CA2660034A1 (en) 2008-02-14
WO2008017928A2 (en) 2008-02-14
EP1887361A1 (en) 2008-02-13
JP2010500545A (en) 2010-01-07

Similar Documents

Publication Publication Date Title
WO2008017928A3 (en) Method for the prediction of vascular events and the diagnosis of acute coronary syndrome
WO2008015254A3 (en) Means and methods for assessing the risk of cardiac interventions based on gdf-15
WO2007116226A3 (en) Blood glucose monitoring systems
EP2804001A3 (en) Methods for diagnosing prostate carcinomas
FI3312749T3 (en) Methods and apparatuses for predicting risk of prostate cancer and prostate gland volume
EP2369346A3 (en) Means and method for diagnosing diabetes
WO2010025393A3 (en) Protein biomarkers and methods for diagnosing kawasaki disease
WO2005071407A3 (en) Methods of diagnosing acute coronary syndrome by measuring urotensin ii
WO2008089994A8 (en) Use of igfbp-7 in the assessment of heart failure
JP2014514536A5 (en)
WO2009101059A3 (en) Methods of using cadherin 11 (cdh11) antagonists
NZ576061A (en) Biomarkers
RU2014140608A (en) PREDICTION OF OUTCOMES IN PATIENTS WITH CHRONIC OBSTRUCTIVE LUNG DISEASE
WO2008109075A3 (en) Biomarkers and methods for determining sensitivity to ctla-4 antagonists
DE602006003411D1 (en) Use of cardiac hormones to diagnose cardiovascular risk as a result of anti-inflammatory administration
WO2007140185A3 (en) Methods for non-invasive analyte measurement
WO2006092729A3 (en) Novel biomarkers for diagnosis and/or prognosis or prognosis of neoplasias in animals
WO2008129296A3 (en) Disease markers
WO2010061283A3 (en) Biomarkers for diagnosing and detecting the progression of neurodegenerative disorders, in particular of amyotrophic lateral sclerosis
WO2011012268A8 (en) Use of mimecan in the assessment of heart failure
DE602006017058D1 (en) METHOD FOR STRATIFYING CARDIAC SUFFICIENCY
WO2002047026A3 (en) Method for determining competing risks
WO2004089184A3 (en) NEW USES OF Lp-PLA2 IN COMBINATION TO ASSESS CORONARY RISK
RU2015129496A (en) ACUTE KIDNEY FAILURE
WO2007079301A3 (en) Method of diagnosing a body weight condition or predisposition in an animal

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200780036699.5

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07804722

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2007804722

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 12309870

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2660034

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2009523365

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU